Designing and Development of imidazol-5-ones as NNRTIs
(Sprache: Englisch)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) of HIV-1 are an important part of currently available anti-HIV therapies because of their diversity and specificity in targeting this enzyme. The use of NNRTIs in the clinic still remains subject to...
Leider schon ausverkauft
versandkostenfrei
Buch
54.90 €
27 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Designing and Development of imidazol-5-ones as NNRTIs “
Klappentext zu „Designing and Development of imidazol-5-ones as NNRTIs “
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) of HIV-1 are an important part of currently available anti-HIV therapies because of their diversity and specificity in targeting this enzyme. The use of NNRTIs in the clinic still remains subject to the rapid emergence of drug resistance due to mutation of the HIV-RT enzyme and this limits therapeutic options. So there is need to discover new chemical entity having broad spectrum activity against reverse transcriptase enzyme.
Autoren-Porträt von Santosh Mokale
Mokale, SantoshDr. Santosh N. Mokale, M.Pharm Ph.D. is working as Professor at Y. B. Chavan College of Pharmacy, Aurangabad (MS). He has around 17 years of professional experience and has published 30 research papers with cumulative impact factor more than 50. He is recipient of YOUNG SCIENTIST award from DST and research grants Rs. 45 Lack from DST and UGC
Bibliographische Angaben
- Autor: Santosh Mokale
- 2016, 112 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: LAP Lambert Academic Publishing
- ISBN-10: 3659880779
- ISBN-13: 9783659880773
Sprache:
Englisch
Kommentar zu "Designing and Development of imidazol-5-ones as NNRTIs"
0 Gebrauchte Artikel zu „Designing and Development of imidazol-5-ones as NNRTIs“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Designing and Development of imidazol-5-ones as NNRTIs".
Kommentar verfassen